Association of (N251S)-PIP5K2A with schizophrenic disorders: A study of the Russian population of Siberia

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 113, Issue 5, 2013, Pages 58-61

  Fedorenko, O Yu ^a,b   Rudikov, E V ^a   Gavrilova, V A ^a   Boyarko, E G ^a   Semke, A V ^a   Ivanova, S A ^a  

^a MENTAL HEALTH RESEARCH INSTITUTE   (Russian Federation)

^b PERM NATIONAL RESEARCH POLYTECHNIC UNIVERSITY   (Russian Federation)

Author keywords

Association; PIP5K2A; Schizophrenia

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3; POTASSIUM CHANNEL KCNQ;

ARTICLE; CONTROLLED STUDY; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE 2A GENE; RUSSIAN FEDERATION; SCHIZOPHRENIA;

EID: 84922686995     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bakker S.C., Hoogendoorn M.L., Hendriks J. et al. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav 2007; 6: 113-119.
2. Di Paolo G., De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006; 443: 651-657.
3. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 2000; 62: 6: 649-671.
4. Faraone S.V., Matise T., Svrakic D. et al. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 1998; 81: 4: 290-295.
5. Fedorenko O., Strutz-Seebohm N., Henrion U. et al. A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M-channels. Psychopharmacology 2008; 199: 1: 47-54.
6. Fedorenko O., Tang C., Sopjani M. et al. PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3. Psychopharmacology 2009; 206: 3: 429-435.
7. Gamper N., Shapiro M.S. Regulation of ion transport proteins by membrane phosphoinositides. Nat Rev Neurosci 2007; 8: 12: 921-934.
8. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 1: 40-68.
9. He Z., Li Z., Shi Y. et al. The PIP5K2A gene and schizophrenia in the Chinese population-a case-control study. Schizophr. Res 2007; 94: 359-365.
10. Jamra R.A., Klein K., Villela A.W. et al. Association study between genetic variants at the PIP5K2A gene locus and schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 6: 663-665.
11. Levinson D.F., Holmans P., Straub R.E. et al. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 2000; 67: 3: 652-663.
12. Li J.Z., Absher D.M., Tang H. et al. Worldwide human relationships inferred from genome-wide patterns of variation. Science 2008; 319: 1100-1104.
13. Nelis M., Esko T., Magi R. et al. Genetic structure of Europeans: a view from the North-East. PLoS ONE 2009; 4: 5: e5472.
14. Rajeevan H., Osier M.V., Cheung K.H., et al. ALFRED-the Allele Frequency Database-update. Nucleic Acids Research 2003; 31: 1: 270-271.
15. Rameh L.E., Tolias K.F., Duckworth B.C. et al. A new pathway for synthesis of phosphatidylinositol-4,5 bisphosphate. Nature 1997; 390: 192-196.
16. Saggers-Gray L., Heriani H., Handoko H.Y. et al. Association of PIP5K2A with schizophrenia: a study in an indonesian family sample. Am J Med Genet B Neuropsychiatr Genet 2008; 147: 7: 1310-1313.
17. Schwab S.G., Hallmayer J., Albus M. et al. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet 1998; 81: 4: 302-307.
18. Schwab S.G., Knapp M., Sklar P. et al. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol. Psychiatry 2006; 11: 837-846.
19. Shanker G., Aschner M.J. Identification and characterization of uptake systems for cystine and cysteine in cultured astrocytes and neurons: evidence for methylmercury-targeted disruption of astrocyte transport. Neurosci Res 2001; 66: 5: 998-1002.
20. Stopkova P., Saito T., Fann C.S. et al. Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet 2003; 123: 50-58.
21. Straub R.E., MacLean C.J., Martin R.B. et al. A schizophrenia locus may be located in region 10p15-p11. Am J Med Genet 1998; 81: 4: 296-301.
22. Suh B.C., Hille B. PIP2 is a necessary cofactor for ion channel function: how and why? Annu Rev Biophys 2008; 37: 175-195.
23. The International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449: 851-861.
24. Wulff H., Castle N.A., Pardo L.A. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 2009; 8: 12: 982-1001.